Clinical trials
Recruiting Astrocytoma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nationwide Children's Hospital | 2 |
| AstraZeneca | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Northern Care Alliance NHS Foundation Trust | 1 |
| Rigel Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astrocytoma | 6 |
| Glioma | 4 |
| Brain Neoplasms | 3 |
| Diffuse Intrinsic Pontine Glioma | 3 |
| Glioblastoma | 3 |
| Breast Neoplasms | 1 |
| Fallopian Tube Neoplasms | 1 |
| Neuroma, Acoustic | 1 |
| Oligodendroglioma | 1 |
| Ovarian Neoplasms | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.